Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the Congo.

Mulangu S, Alfonso VH, Hoff NA, Doshi RH, Mulembakani P, Kisalu NK, Okitolonda-Wemakoy E, Kebela BI, Marcus H, Shiloach J, Phue JN, Wright LL, Muyembe-Tamfum JJ, Sullivan NJ, Rimoin AW.

J Infect Dis. 2018 Jan 30;217(4):529-537. doi: 10.1093/infdis/jix619.

PMID:
29329455
2.

High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo.

Mulangu S, Borchert M, Paweska J, Tshomba A, Afounde A, Kulidri A, Swanepoel R, Muyembe-Tamfum JJ, Van der Stuyft P.

BMC Infect Dis. 2016 Jun 10;16:263. doi: 10.1186/s12879-016-1607-y.

3.

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.

Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, Shi W, Choe M, Marcus H, Thompson EA, Cagigi A, Silacci C, Fernandez-Rodriguez B, Perez L, Sallusto F, Vanzetta F, Agatic G, Cameroni E, Kisalu N, Gordon I, Ledgerwood JE, Mascola JR, Graham BS, Muyembe-Tamfun JJ, Trefry JC, Lanzavecchia A, Sullivan NJ.

Science. 2016 Mar 18;351(6279):1339-42. doi: 10.1126/science.aad5224. Epub 2016 Feb 25.

4.

Structural and molecular basis for Ebola virus neutralization by protective human antibodies.

Misasi J, Gilman MS, Kanekiyo M, Gui M, Cagigi A, Mulangu S, Corti D, Ledgerwood JE, Lanzavecchia A, Cunningham J, Muyembe-Tamfun JJ, Baxa U, Graham BS, Xiang Y, Sullivan NJ, McLellan JS.

Science. 2016 Mar 18;351(6279):1343-6. doi: 10.1126/science.aad6117. Epub 2016 Feb 25.

5.

A new approach for monitoring ebolavirus in wild great apes.

Reed PE, Mulangu S, Cameron KN, Ondzie AU, Joly D, Bermejo M, Rouquet P, Fabozzi G, Bailey M, Shen Z, Keele BF, Hahn B, Karesh WB, Sullivan NJ.

PLoS Negl Trop Dis. 2014 Sep 18;8(9):e3143. doi: 10.1371/journal.pntd.0003143. eCollection 2014 Sep.

6.

Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial.

Sarwar UN, Costner P, Enama ME, Berkowitz N, Hu Z, Hendel CS, Sitar S, Plummer S, Mulangu S, Bailer RT, Koup RA, Mascola JR, Nabel GJ, Sullivan NJ, Graham BS, Ledgerwood JE; VRC 206 Study Team.

J Infect Dis. 2015 Feb 15;211(4):549-57. doi: 10.1093/infdis/jiu511. Epub 2014 Sep 14.

7.

Ebola virus outbreaks in Africa: past and present.

Muyembe-Tamfum JJ, Mulangu S, Masumu J, Kayembe JM, Kemp A, Paweska JT.

Onderstepoort J Vet Res. 2012 Jun 20;79(2):451. doi: 10.4102/ojvr.v79i2.451. Review.

PMID:
23327370
8.

Ebolavirus vaccines for humans and apes.

Fausther-Bovendo H, Mulangu S, Sullivan NJ.

Curr Opin Virol. 2012 Jun;2(3):324-9. doi: 10.1016/j.coviro.2012.04.003. Epub 2012 May 4. Review.

9.

Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge.

Geisbert TW, Bailey M, Hensley L, Asiedu C, Geisbert J, Stanley D, Honko A, Johnson J, Mulangu S, Pau MG, Custers J, Vellinga J, Hendriks J, Jahrling P, Roederer M, Goudsmit J, Koup R, Sullivan NJ.

J Virol. 2011 May;85(9):4222-33. doi: 10.1128/JVI.02407-10. Epub 2011 Feb 16.

10.

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.

Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, Koup RA, Roederer M, Bailer R, Mascola JR, Pau MG, Sullivan NJ, Goudsmit J, Nabel GJ, Graham BS; VRC 205 Study Team.

Vaccine. 2010 Dec 16;29(2):304-13. doi: 10.1016/j.vaccine.2010.10.037. Epub 2010 Oct 27.

PMID:
21034824
11.

Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species.

Hensley LE, Mulangu S, Asiedu C, Johnson J, Honko AN, Stanley D, Fabozzi G, Nichol ST, Ksiazek TG, Rollin PE, Wahl-Jensen V, Bailey M, Jahrling PB, Roederer M, Koup RA, Sullivan NJ.

PLoS Pathog. 2010 May 20;6(5):e1000904. doi: 10.1371/journal.ppat.1000904.

12.

Baseline assessment of collaborative tuberculosis/HIV activities in Kinshasa, the Democratic Republic of Congo.

Martinot A, Van Rie A, Mulangu S, Mbulula M, Jarrett N, Behets F, Bola V, Bahati E.

Trop Doct. 2008 Jul;38(3):137-41. doi: 10.1258/td.2007.070063.

PMID:
18628533
13.

Use of protective gear and the occurrence of occupational Marburg hemorrhagic fever in health workers from Watsa health zone, Democratic Republic of the Congo.

Borchert M, Mulangu S, Lefevre P, Tshomba A, Libande ML, Kulidri A, Muyembe-Tamfum JJ, Van der Stuyft P.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S168-75.

PMID:
17940946
14.

Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment.

Colebunders R, Tshomba A, Van Kerkhove MD, Bausch DG, Campbell P, Libande M, Pirard P, Tshioko F, Mardel S, Mulangu S, Sleurs H, Rollin PE, Muyembe-Tamfum JJ, Jeffs B, Borchert M; International Scientific and Technical Committee "DRC Watsa/Durba 1999 Marburg Outbreak Investigation Group".

J Infect Dis. 2007 Nov 15;196 Suppl 2:S148-53.

PMID:
17940943
15.

Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray.

de Souza Luna LK, Heiser V, Regamey N, Panning M, Drexler JF, Mulangu S, Poon L, Baumgarte S, Haijema BJ, Kaiser L, Drosten C.

J Clin Microbiol. 2007 Mar;45(3):1049-52. Epub 2007 Jan 17.

16.

Marburg hemorrhagic fever associated with multiple genetic lineages of virus.

Bausch DG, Nichol ST, Muyembe-Tamfum JJ, Borchert M, Rollin PE, Sleurs H, Campbell P, Tshioko FK, Roth C, Colebunders R, Pirard P, Mardel S, Olinda LA, Zeller H, Tshomba A, Kulidri A, Libande ML, Mulangu S, Formenty P, Grein T, Leirs H, Braack L, Ksiazek T, Zaki S, Bowen MD, Smit SB, Leman PA, Burt FJ, Kemp A, Swanepoel R; International Scientific and Technical Committee for Marburg Hemorrhagic Fever Control in the Democratic Republic of the Congo.

N Engl J Med. 2006 Aug 31;355(9):909-19.

17.

Serosurvey on household contacts of Marburg hemorrhagic fever patients.

Borchert M, Mulangu S, Swanepoel R, Libande ML, Tshomba A, Kulidri A, Muyembe-Tamfum JJ, Van der Stuyft P.

Emerg Infect Dis. 2006 Mar;12(3):433-9.

18.

Lessons from the outbreak of Marburg virus.

Borchert M, Mulangu S, Van der Stuyft P.

N Engl J Med. 2005 Sep 15;353(11):1185. No abstract available.

19.

Pygmy populations seronegative for Marburg virus.

Borchert M, Mulangu S, Swanepoel R, Tshomba A, Afounde A, Kulidri A, Muyembe-Tamfum JJ, Van der Stuyft P.

Emerg Infect Dis. 2005 Jan;11(1):174-7. No abstract available.

20.

[Histo-topographic variations of pharyngolaryngeal cancer].

Mulangu S, Ionescu R.

Ann Otolaryngol Chir Cervicofac. 1975 Jan-Feb;92(1-2):73-8. French.

PMID:
1217803
21.

[2 cases of late decompression in so-called frozen face paralysis].

Ionesco R, Mulangu S.

Rev Laryngol Otol Rhinol (Bord). 1974 Nov-Dec;95(11-12):775-9. French. No abstract available.

PMID:
4469661

Supplemental Content

Loading ...
Support Center